Parkes RK - Search Results

1

COPS3 amplification and clinical outcome in osteosarcoma.

Yan T, Wunder JS, Gokgoz N, Gill M, Eskandarian S, Parkes RK, Bull SB, Bell RS, Andrulis IL. Yan T, et al. Among authors: parkes rk. Cancer. 2007 May 1;109(9):1870-6. doi: 10.1002/cncr.22595. Cancer. 2007. PMID: 17366602 Free article.

2

TP53 mutations and outcome in osteosarcoma: a prospective, multicenter study.

Wunder JS, Gokgoz N, Parkes R, Bull SB, Eskandarian S, Davis AM, Beauchamp CP, Conrad EU, Grimer RJ, Healey JH, Malkin D, Mangham DC, Rock MJ, Bell RS, Andrulis IL. Wunder JS, et al. J Clin Oncol. 2005 Mar 1;23(7):1483-90. doi: 10.1200/JCO.2005.04.074. J Clin Oncol. 2005. PMID: 15735124

3

Characterization of the 12q15 MDM2 and 12q13-14 CDK4 amplicons and clinical correlations in osteosarcoma.

Mejia-Guerrero S, Quejada M, Gokgoz N, Gill M, Parkes RK, Wunder JS, Andrulis IL. Mejia-Guerrero S, et al. Among authors: parkes rk. Genes Chromosomes Cancer. 2010 Jun;49(6):518-25. doi: 10.1002/gcc.20761. Genes Chromosomes Cancer. 2010. PMID: 20196171

4

HER-2/neu status and tumor morphology of invasive breast carcinomas in Ashkenazi women with known BRCA1 mutation status in the Ontario Familial Breast Cancer Registry.

Quenneville LA, Phillips KA, Ozcelik H, Parkes RK, Knight JA, Goodwin PJ, Andrulis IL, O'Malley FP. Quenneville LA, et al. Among authors: parkes rk. Cancer. 2002 Nov 15;95(10):2068-75. doi: 10.1002/cncr.10949. Cancer. 2002. PMID: 12412159 Free article.

5

Amplification of the TOP2A gene does not predict high levels of topoisomerase II alpha protein in human breast tumor samples.

Mueller RE, Parkes RK, Andrulis I, O'Malley FP. Mueller RE, et al. Among authors: parkes rk. Genes Chromosomes Cancer. 2004 Apr;39(4):288-97. doi: 10.1002/gcc.20008. Genes Chromosomes Cancer. 2004. PMID: 14978790

6

Angiotensinogen M235T genotype predicts progression in chronic renal allograft dysfunction.

Prasad GV, Pinnaduwage D, Parkes RK, Midgley J, Balfe JW, Hegele RA, Bull SB, Cole EH, Logan AG. Prasad GV, et al. Among authors: parkes rk. Transplantation. 2003 Jan 27;75(2):209-16. doi: 10.1097/01.TP.0000040866.14123.05. Transplantation. 2003. PMID: 12548125

7

Invasive lobular carcinoma: to grade or not to grade.

Bane AL, Tjan S, Parkes RK, Andrulis I, O'Malley FP. Bane AL, et al. Among authors: parkes rk. Mod Pathol. 2005 May;18(5):621-8. doi: 10.1038/modpathol.3800273. Mod Pathol. 2005. PMID: 15605082 Free article.

8

Comparison of HER2/neu status assessed by quantitative polymerase chain reaction and immunohistochemistry.

O'Malley FP, Parkes R, Latta E, Tjan S, Zadro T, Mueller R, Arneson N, Blackstein M, Andrulis I. O'Malley FP, et al. Am J Clin Pathol. 2001 Apr;115(4):504-11. doi: 10.1309/VP4W-5C55-7M09-6TX3. Am J Clin Pathol. 2001. PMID: 11293897

9

A clinicobiological model predicting survival in medulloblastoma.

Ray A, Ho M, Ma J, Parkes RK, Mainprize TG, Ueda S, McLaughlin J, Bouffet E, Rutka JT, Hawkins CE. Ray A, et al. Among authors: parkes rk. Clin Cancer Res. 2004 Nov 15;10(22):7613-20. doi: 10.1158/1078-0432.CCR-04-0499. Clin Cancer Res. 2004. PMID: 15569993

10

The role of HER2/neu overexpression/amplification in the progression of ductal carcinoma in situ to invasive carcinoma of the breast.

Latta EK, Tjan S, Parkes RK, O'Malley FP. Latta EK, et al. Among authors: parkes rk. Mod Pathol. 2002 Dec;15(12):1318-25. doi: 10.1097/01.MP.0000038462.62634.B1. Mod Pathol. 2002. PMID: 12481013

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

26 results

Search Page